R-PHARM US is engaged in the discovery and development of proprietary NME prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.
上海毕得医药科技股份有限公司400-1647117 13681763483product02@bidepharm.com中国6216358 InvivoChem中国13549236410sales@invivochem.cn中国675558 常州博嘉生物医药科技有限公司2122619822czbjpharma@126.com中国1848858 武汉英诺医药科技有限公司+86-027-59232304 153870631012881924050@qq.com中国996758 ...
PHARMACOMPASS Grow Your Pharma Business Digitally Find Suppliers (API/FDF) Services Search for Service - Analytical - Analytical Method Development - Biologic Drugs - Capillary Electrophoresis - Chiral HPLC & SFC Method Development - Impurity Isolation and Identification - Method Development and Vali...
Contact Supplier Virtual Booth ContactSupplier Virtual Booth ContactSupplier Xls Registrant Name 1All 1Cambrex Profarmaco Milano S. r. l. ResetOK Classification ResetOK Country ResetOK 01 Cambrex Profarmaco Milano S. r. l. U.S.A SupplySide West 2024 ...
shanghai cooperpharm co.,LTD 3-(1-Aminoethyl)phenol hydrochloride Products(914) Shanghai Hao Teng Biological Technology Co., Ltd. (R)-3-(1-AMINOETHYL)PHENOL Products(580) Allichem LLC Phenol,3-[(1R)-1-aminoethyl]- Products(36) Shanghai ChunHe Biotechnology CO.,Ltd (R)-3-(1-...
Name of Company JSC R-Pharm Head office Moscow, Russian Federation Establishment 2001 Representative Alexey Repik Shareholders (after participation by Mitsui) R-Pharm Holding LLC : Approx.90%, Mitsui's SPC : Approx.10% Employees Approx. 3,600 Business Activities Development, manufacturing, procurement...
toxics Article Cytotoxicity and Toxicity Evaluation of Xanthone Crude Extract on Hypoxic Human Hepatocellular Carcinoma and Zebrafish (Danio rerio) Embryos Shazrul Fazry 1,2,* , Muhammad Akram Mohd Noordin 1, Salahuddin Sanusi 3, Mahanem Mat Noor 1, Wan Mohd Aizat 3 , Azwan Mat Lazim 1,2,...
Chem. Pharm. Bull. 1977, 25, 1764–1770. [CrossRef] 11. Yenesew, D.E.; Muller, M.; Steglich, W. An Anthraquinone and two oxanthrones from Kniphonia foliosa. Phytochemistry 1994, 37, 525–528. [CrossRef] 12. Li, C.; Shi, J.G.; Zhang, Y.P.; Zhang, C.Z. Constituents of...
In April 2019, Novaliq has founded Betaliq Inc., Tampa, USA in collaboration with BLP Management Group, LLC. Betaliq develops the ophthalmic beta-blocker BTQ 1902 using Novaliq’s proprietary EyeSol® water-free technology. In the US Phase 2 study BTQ-1902 met the study goal of statistical...
上海毕得医药科技股份有限公司400-1647117 13681763483product02@bidepharm.com中国6216358 湖南增达生物科技有限公司187110856001652923704@qq.com中国458258 TargetMol中国(陶术生物)4008200310marketing@tsbiochem.com中国2464958 湖北国云福瑞科技有限公司18162595016; 181625950163287908757@qq.com中国1033658 ...